• Aftab Alam Khan Department of Psychiatry, Ayub Medical College, Abbottabad, Pakistan
  • Haq Nawaz Department of Pharmacology, Ayub Medical College, Abbottabad, Pakistan
  • Zainab Nazneen Department of Community Medicine, Ayub Medical College, Abbottabad, Pakistan
  • Aziz Ur-Rehman Yousafzai Department of Psychiatry, Women Medical College, Abbottabad, Pakistan


Sexual Dysfunction, Antipsychotics, Erectile dysfunction, Ejaculatory dysfunction, Orgasmic dysfunction, libido


Background: Sexual dysfunction associated with the use of antipsychotic drugs is quite prevalent affecting the patients’ quality of life and one of the reasons for non-compliance. This important aspect is underestimated and overlooked by the treating professionals, partly because patients rarely talk about their dysfunction. Due to the scarcity of local data on the subject the objective of the present study was to explore and compare the prevalence of sexual dysfunction associated with antipsychotic drugs. Methods: This was a hospital-based cross-sectional study comprising of comparative assessment among five antipsychotics being consumed by 91 male patients under this study. Results: Risperidone, haloperidol and olanzapine collectively as a group were associated with increased incidence of sexual dysfunction (42.43%) compared to quetiapine and aripiprazole group (16%) which was statistically significant. Individually risperidone (48%) and haloperidol (45.81%) were associated with highest incidence of sexual dysfunction followed by olanzapine (29.41%). Quetiapine (16.67%) and aripiprazole (15.38%) were associated with the lowest incidence of sexual dysfunction. Conclusion: Risperidone and haloperidol are associated with a higher rate of sexual dysfunction compared to olanzapine. Quetiapine and aripiprazole have a significantly lower profile of adverse effects on sexual function.

Pak J Physiol 2017;13(3):3–7


Download data is not yet available.

Author Biography

Haq Nawaz, Department of Pharmacology, Ayub Medical College, Abbottabad, Pakistan

Dr. Haq Nawaz,

Department of Pharmacology and Therapeutics,

Ayub Medical College, Abbottabad-22040, Pakistan.

Cell: +92-345-9627240



1. Berner M. Sexual dysfunction associated with psychotropic drugs and treatment options. Nervenarzt 2017;88(5):459–65.
2. Therapeutic issues. In: Semple D, Smyth R, (Eds). Oxford Handbook of Psychiatry. 3rd ed. UK: Oxford University Press; 2013. p. 923–80.
3. Soldati L. Sexual dysfunction among patients with psychiatric disorders. Rev Med Suisse 2016;12(510):544–7.
4. Shah SK. A comparative study of sexual dysfunction in schizophrenia patients taking aripiprazole versus risperidone. Kathmandu Univ Med J 2013;11(42):121–5.
5. Park YW, Kim Y, Lee JH. Antipsychotic induced sexual dysfunction and its management. World J Mens Health 2012;30(3):153–9.
6. Baggaley M. Sexual dysfunction in schizophrenia: focus on recent evidence. Hum Psychopharmacol 2008;23(3):201–9.
7. Haefliger T, Bonsack C. Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone. Encephale 2006;32(1 Pt 1):97–105.
8. Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM. Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev 2012;11. doi: 10.1002/14651858.CD003546.pub3.
9. Yektas C, Tufan AE. Spontaneous ejaculations in an aolescent with Olanzapine use: Case Report. Clin Neuropharmacol 2016;39(3):157–8.
10. Khawaja MY. Sexual dysfunction in male patients taking antipsychotics. J Ayub Med Coll Abottabad 2005;17(3):73–5.
11. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26(1):25–40.
12. Sathish Kumar SV, Sinha VK. Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia. Indian J Psychiatry 2015;57:386–91.
13. Montejo AL, Majadas S, Rico-Villademoros F, Llorca G, De La Gandara J, Franco M, et al. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med 2010;7(10):3404–13.
14. Park YM, Lee SH, Lee BH, Lee KY, Lee KS, Kang SG, et al. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study. Psychiatry Res 2016;239:184–9.
15. Oyekanmi AK, Adelufosi AO, Abayomi O, Adebowale TO. Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications. BMC Res Notes 2012;5:267.
16. Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol 2011;26(3):130–40.
17. Smith SM, O’Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002;181:49–55.
18. Nagaraj AK, Nizamie SH, Akhtar S, Sinha BN, Goyal N. A comparative study of sexual dysfunction due to typical and atypical antipsychotics in remitted bipolar I disorder. Indian J Psychiatry 2004;46:261–6.
19. Knegtering H, van den Bosch R, Castelein S, Bruggeman R, Sytema S, van Os J. Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology 2008;33(6):711–7.
20. Bobes J, Garc A-Portilla MP, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: the results of EIRE study. J Sex Marital Ther 2003;29;125–47.
21. Bitter I, Basson BR, Dossenbach MR. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 2005;20(1):19–21.
22. Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC. Sexual side effects of novel antipsychotic medications. Schizophr Res 2002;56(1–2):25–30.
23. Knegtering H, Boks M, Blijd C, Castelein S, Van den Bosch RJ, Wiersma D. A randomized open-labelled comparison of the impact of olanzapine vs risperidone on sexual functioning. J Sex Marital Ther 2006;32;315–26.
24. Nagaraj AK, Pai NB, Rao S. A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine. Indian J Psychiatry 2009;51(4):265–71.
25. Nakonezny PA, Byerly MJ, Rush AJ. The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs quetiapine. J Sex Marital Ther 2007;33(3):203–16.
26. Byerly MJ, Lescouflair E, Weber MT, Bugno RM, Fisher R, Carmody T, et al. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction. J Sex Marital Ther 2004;30(5):325–32.
27. Atmaca M, Kuloglu M, Tezcan E. A new atypical antipsychotic: Quetiapine-induced sexual dysfunctions. Int J Impot Res 2005;17(2):201–3.
28. Kelly DL, Conley RR. A randomized double-blind 12 week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 2006;31:340–6.
29. Jeong HG, Lee MS, Lee HY, Ko YH, Han C, Joe SH. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. Int Clin Psychopharmacol 2012;27(4):177–83.




How to Cite

Khan AA, Nawaz H, Nazneen Z, Yousafzai AU-R. ANTI-PSYCHOTICS INDUCED SEXUAL DYSFUNCTION. Pak J Phsyiol [Internet]. 2017 Sep. 30 [cited 2024 Jun. 13];13(3):3-7. Available from: